Accelerated Approval: Adcomm Should Always Precede Withdrawal Proposal, US FDA Says

 
• By Sue Sutter
  
Skipping rope
The FDA does not want its centers to skip an advisory committee meeting when proposing to withdraw an accelerated approval product. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards